The Institute of Pennsylvania Hospital, also known as Kirkbride's Hospital or the Pennsylvania Hospital for Mental and Nervous Diseases, was a psychiatric hospital located at 48th and Haverford Streets in Philadelphia, Pennsylvania, USA. It operated from its founding in 1841 until 1997.

During the past decade, CRI Worldwide - Kirkbride Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CRI Worldwide - Kirkbride Center" are "Schizoaffective Disorder" (2 trials) and "Schizophrenia" (2 trials). Many other conditions were trialed in "CRI Worldwide - Kirkbride Center" in a lesser frequency.

Most popular intervention types in "CRI Worldwide - Kirkbride Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lurasidone HCl" (2 trials). Other intervention names were less common.

The vast majority of trials in "CRI Worldwide - Kirkbride Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CRI Worldwide - Kirkbride Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CRI Worldwide - Kirkbride Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CRI Worldwide - Kirkbride Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".